このエントリーをはてなブックマークに追加
ID 68364
FullText URL
fulltext.pdf 1.98 MB
Author
Sato, Ryosuke Department of Gastroenterology and Hepatology, Okayama University Hospital
Matsumoto, Kazuyuki Department of Gastroenterology and Hepatology, Okayama University Hospital ORCID Kaken ID publons
Uka, Mayu Department of Radiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Takagi, Kosei Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Nishida, Kenji Department of Pathology, Dentistry and Pharmaceutical Science, Okayama University Graduate School of Medicine
Tanaka, Takehiro Department of Pathology, Dentistry and Pharmaceutical Science, Okayama University Graduate School of Medicine ORCID Kaken ID publons
Fujii, Yuki Department of Gastroenterology and Hepatology, Okayama University Hospital
Tsutsumi, Koichiro Department of Gastroenterology and Hepatology, Okayama University Hospital ORCID Kaken ID researchmap
Horiguchi, Shigeru Department of Gastroenterology and Hepatology, Okayama University Hospital
Otsuka, Motoyuki Department of Gastroenterology and Hepatology, Okayama University Hospital
Abstract
We herein report a case of pancreatic ductal adenocarcinoma (PDAC) that developed within the pancreatic duct and was initially diagnosed as an intraductal tubulopapillary neoplasm (ITPN). A 76-year-old man presented with weight loss and main pancreatic duct dilation. The imaging studies revealed a 30-mm hypovascular tumor within the main duct of the pancreatic head. An endoscopic examination with a biopsy revealed high-grade atypical epithelial cells with immunostaining patterns suggestive of ITPN. Following robot-assisted pancreaticoduodenectomy, postoperative pathology revealed conflicting features: nodular/cribriform infiltrations typical of ITPN and non-lobular replacement with scattered infiltrations characteristic of PDAC. A comprehensive genomic profiling test detected KRAS and TP53 mutations, leading to the final diagnosis of PDAC (fT3N1aM0, stage IIB). The patient received adjuvant S-1 chemotherapy and remained recurrence-free for 15 months post-surgery. This case highlights the diagnostic challenges of differentiating intraductal pancreatic tumors and demonstrates the utility of integrating genetic testing with conventional diagnostic modalities for an accurate diagnosis and appropriate treatment selection.
Keywords
Pancreatic intraductal neoplasms
Pancreatic carcinoma
Intraductal tubulopapillary neoplasm
Genetic testing
Note
The version of record of this article, first published in Clinical Journal of Gastroenterology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s12328-025-02098-y
Published Date
2025-02-05
Publication Title
Clinical Journal of Gastroenterology
Volume
volume18
Issue
issue2
Publisher
Springer Science and Business Media LLC
Start Page
376
End Page
382
ISSN
1865-7257
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© The Author(s) 2025
File Version
publisher
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.1007/s12328-025-02098-y
License
http://creativecommons.org/licenses/by/4.0/
Citation
Sato, R., Matsumoto, K., Uka, M. et al. A case of pancreatic ductal adenocarcinoma growing within the pancreatic duct mimicking an intraductal tubulopapillary neoplasm. Clin J Gastroenterol 18, 376–382 (2025). https://doi.org/10.1007/s12328-025-02098-y
Funder Name
Okayama University